Todd Harris, President and CEO at Tyra Biosciences, Inc. (TYRA), sold 21,839 shares at $24.13 ($527K) on 2024-09-23, disclosed to the SEC on 2024-09-25.
Scheduled sale ($527k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $24.13 | 10,092 | $244K | 46.2% |
| 2 | $24.13 | 10,092 | $244K | 46.2% |
| 3 | $24.02 | 1,055 | $25K | 4.8% |
| 4 | $24.01 | 600 | $14K | 2.7% |
| Total | $24.12 avg | 21,839 | $527K | 100% |
| Filing → |
| TYRA | SELL | 2024-10-02 | $12K | — | Filing → |
| TYRA | SELL | 2024-09-20 | $704K | — | Filing → |
| TYRA | SELL | 2024-02-06 | $3.3M | — | Filing → |